Antibacterial activity of trovafloxacin against gram-positive blood culture isolates from nosocomial infections
- 1 August 1996
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 15 (8) , 694-696
- https://doi.org/10.1007/bf01691163
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Etiology of nosocomial infections and the susceptibility of nosocomial pathogens to imipenem and other antimicrobial agents at a tertiary care referral hospitalCurrent Therapeutic Research, 1995
- In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobialDiagnostic Microbiology and Infectious Disease, 1994
- In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteriaAntimicrobial Agents and Chemotherapy, 1993
- Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989The American Journal of Medicine, 1991
- THE EVOLUTION OF FLUORINATED QUINOLONES: Pharmacology, Microbiological Activity, Clinical Uses, and ToxicitiesAnnual Review of Microbiology, 1989
- Coagulase-Negative Staphylococcal BacteremiaAnnals of Internal Medicine, 1989
- Hospital-acquired candidemia. The attributable mortality and excess length of stayArchives of internal medicine (1960), 1988
- Hospital-Acquired CandidemiaArchives of internal medicine (1960), 1988